Dynorphin A (1-6) is a truncated opioid segment used to identify minimal motifs contributing to receptor activation. Its compact sequence supports detailed mapping of aromatic and basic residue influence. Researchers analyze its conformational behavior to assess ligand efficiency. The molecule aids structure-activity studies in opioid peptide research.
CAT No: D05055
CAS No:75106-70-6
Synonyms/Alias:Tyr-gly-gly-phe-leu-arg;75106-70-6;6-Arg-leu-enkephalin;Dynorphin A (1-6);82008-60-4;LEU-ENKEPHALIN-ARG;(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid;V1PIQ8ZW62;CHEMBL63188;D-Arginine,N2-[N-[N-[N-(N-L-tyrosylglycyl)glycyl]-L-phenylalanyl]-L-leucyl]- (9CI);enkephalin-Leu, Arg(6)-;Leu-enkephalin, arg(6)-;Leucine-enkephalin, arg(6)-;Enkephalin-leu, arginine(6)-;DYNORPHIN A 1-6;UNII-V1PIQ8ZW62;Tyr-Gly-Gly-Phe-Leu-Arg-OH;DTXSID90996605;BDBM50128084;L-Arginine, N(2)-(N-(N-(N-(N-L-tyrosylglycyl)glycyl)-L-phenylalanyl)-L-leucyl)-;FD108733;H-Tyr-Gly-Gly-Phe-Leu-Arg-OH; H-YGGFLR-OH;alpha-Neoendorphin (pig), 7-de-L-lysine-8-de-L-tyrosine-9-de-L-proline-10-de-L-lysine-;alpha-Neoendorphin, 7-de-L-lysine-8-de-L-tyrosine-9-de-L-proline-10-de-L-lysine-;N~2~-[14-Amino-5-benzyl-1,4,7,10,13-pentahydroxy-15-(4-hydroxyphenyl)-2-(2-methylpropyl)-3,6,9,12-tetraazapentadeca-3,6,9,12-tetraen-1-ylidene]arginine;
3. Implications of ligand-receptor binding kinetics on GLP-1R signalling
5. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More